イムノアッセイ市場 - 戦略と動向：用途別、技術別、製品別、ユーザー別、国別予測 - エグゼクティブコンサルタントガイド付き（2024年～2028年）

診断業界の主力製品が新たな脚光を浴びています。パンデミックは迅速で容易に入手可能な診断薬に対する新たな需要を生み出しました。イムノアッセイはその一翼を担っています。遺伝学的知識の進歩がイムノアッセイに新たな市場を創出しています。マルチプレックスはテーブルステークスとなりつつあります。迅速診断、ポイントオブケア、バイオマーカー、消費者市場が拡大する一方で、伝統的なイムノアッセイ法は成長する臨床診断市場で確固たる地位を維持しています。

当レポートは、世界のイムノアッセイ市場について調査し、市場の概要とともに、用途別、技術別、製品別、ユーザー別、国別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

• イムノアッセイ市場の定義
• 市場の定義
• 調査手法
• 視点：ヘルスケアとIVD業界

第3章 業界の概要

• 市場参入組織
  • 学術研究機関
  • 診断試験開発者
  • 計装サプライヤー
  • 薬品・試薬メーカー
  • 病理サプライヤー
  • 独立系臨床検査室
  • 公共の国立/地域研究所
  • 病院検査室
  • 臨床検査室
  • 監査機関
  • 認証機関
• 臨床検査市場のセグメント
• イムノアッセイ- 市場と議論

第4章 市場動向

• 成長促進要因
• 成長抑制要因
• イムノアッセイ機器

第5章 イムノアッセイ法の最近の進歩

第6章 主要企業のプロファイル

• Abbott Laboratories
• Abcam
• Abionic
• Accel Diagnostics
• Agilent
• Akonni Biosystems
• Applied BioCode
• Arlington Scientific
• Arrayit Corporation
• Atomo Diagnostics
• Aureum Diagnostics
• Aurora Biomed
• Autobio Diagnostics
• AVIVA Systems Biology
• Awareness Technology
• Axis-Shield Diagnostics Ltd.
• Beckman Coulter Diagnostics（Danaher）
• Becton, Dickinson and Company
• Biocartis
• Biomatik
• bioMerieux Diagnostics
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Bio-Synthesis
• Bio-Techne
• Boditech Med, Inc
• Boster Biological Technology
• Bruker
• Cerstest Biotec
• Chembio
• CTK Biotech
• Cue Health
• Cytena
• Diasorin S.p.A.
• Dynex Technologies
• Eiken Chemical
• Enzo Biochem
• Eurofins Scientific
• Fluxion Biosciences（Cell Microsystems）
• FUJIFILM Wako Diagnostics
• Fujirebio
• Global Access Diagnostics
• Gold Standard Diagnostics
• Greiner Bio-One
• Grifols
• Hycor Biomedical
• Immunodiagnostic Systems（IDS）
• Iollo
• JR Biomedical
• LightDeck Diagnostics
• LumiraDx
• Maxim Biomedical
• Meso Scale Discovery
• Millipore Sigma
• Mindray
• Molecular Devices
• MP Biomedical
• Operon
• OraSure Technologies
• Qiagen
• QuidelOrtho
• R&D Systems
• Randox Toxicology
• R-Biopharm AG
• Response Biomedical
• Revvity
• Roche Diagnostics
• SD Biosensor
• Siemens Healthineers
• Standard BioTools
• Sysmex
• Tecan
• Thermo Fisher Scientific
• TOSOH Bioscience
• Uniogen
• Veramarx
• Veredus Laboratories
• Vircell
• Wantai Biopharm
• Werfen
• YD Diagnostics
• Zhejiang Orient Gene Biotech

第7章 世界市場

• 国別世界市場
• 用途別世界市場
• 技術別世界市場
• 製品別世界市場
• ユーザー別世界市場

第8章 世界のイムノアッセイ市場、用途別

• 内分泌学
• 免疫
• 腫瘍学
• 感染症
• 心臓病学
• その他

第9章 世界のイムノアッセイ市場、技術別

• 酵素
• 蛍光
• 化学発光
• 核酸
• 迅速/POC
• その他

第10章 世界のイムノアッセイ市場、製品別

• 機器
• 試薬
• サービス

第11章 世界のイムノアッセイ市場、ユーザー別

• 病院
• 外来検査室
• POC/その他

第12章 イムノアッセイの将来ビジョン

第13章 付録

Table of Tables

• Table 1: Market Players by Type
• Table 2: Clinical Laboratory Departments and Segments
• Table 3: Laboratory Management Focus-Different Approaches
• Table 4: Key Segmentation Variables Going Forward
• Table 5: The Different Markets for Immunoassay
• Table 6: The Factors Driving Growth
• Table 7: Factors Limiting Growth
• Table 8: The Global Immunoassay Market by Country
• Table 9: Global Market by Application
• Table 10: Global Market by Technology
• Table 11: Global Market by Product
• Table 12: Global Market by User
• Table 13: Endocrinology Immunoassay by Country
• Table 14: Immune Immunoassay by Country
• Table 15: Oncology Immunoassay by Country
• Table 16: Infectious Disease Immunoassay by Country
• Table 17: Cardiology Immunoassay by Country
• Table 18: Other Immunoassay by Country
• Table 19: Enzyme Immunoassay by Country
• Table 20: Flourescence Immunoassay by Country
• Table 21: Chemiluminescence Immunoassay by Country
• Table 22: Nucleic Acid Immunoassay by Country
• Table 23: Rapid/POC Immunoassay by Country
• Table 24: Other Technology Immunoassay by Country
• Table 25: Instrument by Country
• Table 26: Reagents by Country
• Table 27: Services by Country
• Table 28: Hospital Usrr by Country
• Table 29: Outpatient Lab by Country
• Table 30: POC/Other by Country
• Table 31: The Most Common Assays
• Table 32: Largest Revenue Assays
• Table 33: Clinical Lab Fee Schedule

Table of Figures

• Figure 1: Global Healthcare Spending
• Figure 2: The Lab Test Pie
• Figure 3: The Road to Diagnostics
• Figure 4: Immunoassay-Country Sharea
• Figure 5: Chart of Growth by Application
• Figure 6: Chart of Segment by Year
• Figure 7: Chart of Base vs. Final
• Figure 8: Chart of Base Year by Application
• Figure 9: Chart of Final Year by Application
• Figure 10: Chart of Growth by Technology
• Figure 11: Chart of Technology Segment by Year
• Figure 12: Chart of Technology Base vs. Final
• Figure 13: Chart of Base Year by Technology
• Figure 14: Chart of Final Year by Technology
• Figure 15: Chart of Growth by Product
• Figure 16: Chart of Product Segment by Year
• Figure 17: Chart of Product Base vs. Final
• Figure 18: Chart of Base Year by Product
• Figure 19: Chart of Final Year by Product
• Figure 20: Chart of Growth by User
• Figure 21: Chart of User Segment by Year
• Figure 22: Chart of User Base vs. Final
• Figure 23: Chart of Base Year by User
• Figure 24: Chart of Final Year by User
• Figure 25: Chart-Endocrine Segment vs Total Market Growth
• Figure 26: Chart-Immune Growth vs. Total
• Figure 27: Chart-Oncology vs Total
• Figure 28: Chart-Infectious Disease Immunoassay vs Total
• Figure 29: Chart-Cardiology Immunoassay vs total
• Figure 30: Chart-Other Immunoassay vs Total
• Figure 31: Chart-Enzyme Segment vs Total Market Growth
• Figure 32: Chart-Flourescence Growth vs. Total
• Figure 33: Chart-Chemiluminescence vs Total
• Figure 34: Chart-Nucleic Acid Immunoassay vs Total
• Figure 35: Chart-Rapid/POC Immunoassay vs total
• Figure 36: Chart-Other Technology Immunoassay vs Total
• Figure 37: Chart-Instrument Segment vs Total Market Growth
• Figure 38: Chart-Reagents Growth vs. Total
• Figure 39: Chart-Services vs Total
• Figure 40: Chart-Hospital Segment vs Total Market Growth
• Figure 41: Chart-Outpatient Lab Growth vs. Total
• Figure 42: Chart-POC/Other vs Total
• Figure 43: IVD Test Menu Growth
• Figure 44: IVD Test Average Fees-A Ten Year View

OVERVIEW:

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Multiplex is becoming table stakes. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile over 80 companies, working in this area. Learn all about the pitfalls and opportunities in this extensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

• B.Sc. (Chemistry) University of BC
• M.B.A. (Finance and Policy) University of BC
• Market Research Seminar - Burke Institute
• Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

• 1.1. Immunoassay Market-Strategic Situation Analysis
• 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

• 2.1. Immunoassay Markets Definition In This Report
  • 2.1.1. Enzyme Based
  • 2.1.2. Immunofluorescence
  • 2.1.3. Chemiluminescence
  • 2.1.4. DNA/NAT
  • 2.1.5. RIA & Other
  • 2.1.6. Reagents/Kits, Analyzers, Software & Services
  • 2.1.7. Infectious Disease
  • 2.1.8. Auto Immune
  • 2.1.9. Endocrinology
  • 2.1.10. Oncology
  • 2.1.11. Cardiology
  • 2.1.12. Other Specialty
• 2.2. Market Definition
  • 2.2.1. Market Sizes
  • 2.2.2. Currency
  • 2.2.3. Years
• 2.3. Methodology
  • 2.3.1. Methodology
  • 2.3.2. Sources
  • 2.3.3. Authors
• 2.4. Perspective: Healthcare and the IVD Industry
  • 2.4.1. Global Healthcare Spending
  • 2.4.2. Spending on Diagnostics
  • 2.4.3. Important Role of Insurance for Diagnostics

3. Industry Overview

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Diagnostic Test Developer
  • 3.1.3. Instrumentation Supplier
  • 3.1.4. Chemical/Reagent Supplier
  • 3.1.5. Pathology Supplier
  • 3.1.6. Independent Clinical Laboratory
  • 3.1.7. Public National/regional Laboratory
  • 3.1.8. Hospital Laboratory
  • 3.1.9. Physicians Office Lab (POLS)
  • 3.1.10. Audit Body
  • 3.1.11. Certification Body
• 3.2. The Clinical Laboratory Market Segments
  • 3.2.1. Traditional Market Segmentation
  • 3.2.2. Laboratory Focus and Segmentation
  • 3.2.3. Hospital Testing Share
  • 3.2.4. Economies of Scale
  • 3.2.5. Hospital vs. Central Lab
  • 3.2.6. Physician Office Lab's
  • 3.2.7. Physician's and POCT
• 3.3. Immunoassay -Markets and Discussion
  • 3.3.1. Instruments-Genetics changes the picture
    • 3.3.1.1. RIA-A Technology Shows its Age
    • 3.3.1.2. Immunoassay vs. PCR vs. Sequencing-A See Saw Battle
    • 3.3.1.3. The Smart Shrinking Instrument-Serious Implications
    • 3.3.1.4. Research Funding and Capital Expense-Instrument Pooling
    • 3.3.1.5. Multiplex vs. POC-A Tradeoff Analysis
  • 3.3.2. Reagents and Kits-Genetics changes the picture
    • 3.3.2.1. Bigger Test Menus a Boon for Kit Market
    • 3.3.2.2. Physician Office Labs-A New Frontier
  • 3.3.3. Rapid and POCT to Threaten Instrument Markets
  • 3.3.4. OTC and DTC-Huge Market Potential
  • 3.3.5. Economies of Scale. Going Away?
  • 3.3.6. Lower Barriers to Entry for Instruments/Analyzers
  • 3.3.7. Miniturization and Technology Drive Acquisition

4. Market Trends

• 4.1. Factors Driving Growth
  • 4.1.1. Diagnostic Factors
  • 4.1.2. Changing Technologies Spur Early Instrument Retirement
  • 4.1.3. Consumer Channels Open Wider
  • 4.1.4. Immunity Technology Comes of Age
• 4.2. Factors Limiting Growth
  • 4.2.1. Increased Competition Lowers Price
  • 4.2.2. Threat from PCR Based Instruments
  • 4.2.3. Lower Barriers to Entry
  • 4.2.4. Wellness has a downside
• 4.3. Immunoassay Instrumentation
  • 4.3.1. Instrumentation Tenacity
  • 4.3.2. Declining Cost of Instruments Changes Industry Structure
  • 4.3.3. Immunoassay-CRISPR Diagnostics

5. Immunoassay Recent Developments

• 5.1. Recent Developments-Importance and How to Use This Section
  • 5.1.1. Importance of These Developments
  • 5.1.2. How to Use This Section
• 5.2. Single-Molecule Detection Tech Shows Promise
• 5.3. QuidelOrtho Vitros Fentanyl Test
• 5.4. Labcorp: Plasma Phosphorylated-Tau 217
• 5.5. Renalytix Gets Immunoassay Medicare Coverage
• 5.6. Roche to Acquire LumiraDx POC Tech
• 5.7. Fujirebio, Sysmex to Collaborate on Immunoassay Development
• 5.8. EDP Biotech, New Day Diagnostics to Merge
• 5.9. Sorrento Therapeutics Nabs Contract for Dx Platform
• 5.10. Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer
• 5.11. Qorvo Eyes Multiplex Immunoassay
• 5.12. BioMerieux Launches New Products
• 5.13. Senzo to Commercialize Infectious Disease Lateral Flow Tests
• 5.14. Nanomix Plans Instrument, Test Launches
• 5.15. Startup GLX Analytix Prepares for Commercialization
• 5.16. Nonagen Gets CE Mark for Bladder Cancer Immunoassay
• 5.17. Qualigen Acquires Majority Stake in NanoSynex
• 5.18. Saladax Biomedical Using Immunoassay Dx
• 5.19. Prolight Diagnostics to Acquire Psyros Diagnostics
• 5.20. Quidel to Acquire Ortho Clinical Diagnostics

6. Profiles of Key Companies

• 6.1. Abbott Laboratories
• 6.2. Abcam
• 6.3. Abionic
• 6.4. Accel Diagnostics
• 6.5. Agilent
• 6.6. Akonni Biosystems
• 6.7. Applied BioCode
• 6.8. Arlington Scientific
• 6.9. Arrayit Corporation
• 6.10. Atomo Diagnostics
• 6.11. Aureum Diagnostics
• 6.12. Aurora Biomed
• 6.13. Autobio Diagnostics
• 6.14. AVIVA Systems Biology
• 6.15. Awareness Technology
• 6.16. Axis-Shield Diagnostics Ltd.
• 6.17. Beckman Coulter Diagnostics (Danaher)
• 6.18. Becton, Dickinson and Company
• 6.19. Biocartis
• 6.20. Biomatik
• 6.21. bioMerieux Diagnostics
• 6.22. Bioneer Corporation
• 6.23. Bio-Rad Laboratories, Inc.
• 6.24. Bio-Synthesis
• 6.25. Bio-Techne
• 6.26. Boditech Med, Inc
• 6.27. Boster Biological Technology
• 6.28. Bruker
• 6.29. Cerstest Biotec
• 6.30. Chembio
• 6.31. CTK Biotech
• 6.32. Cue Health
• 6.33. Cytena
• 6.34. Diasorin S.p.A.
• 6.35. Dynex Technologies
• 6.36. Eiken Chemical
• 6.37. Enzo Biochem
• 6.38. Eurofins Scientific
• 6.39. Fluxion Biosciences (Cell Microsystems)
• 6.40. FUJIFILM Wako Diagnostics
• 6.41. Fujirebio
• 6.42. Global Access Diagnostics
• 6.43. Gold Standard Diagnostics
• 6.44. Greiner Bio-One
• 6.45. Grifols
• 6.46. Hycor Biomedical
• 6.47. Immunodiagnostic Systems (IDS)
• 6.48. Iollo
• 6.49. JR Biomedical
• 6.50. LightDeck Diagnostics
• 6.51. LumiraDx
• 6.52. Maxim Biomedical
• 6.53. Meso Scale Discovery
• 6.54. Millipore Sigma
• 6.55. Mindray
• 6.56. Molecular Devices
• 6.57. MP Biomedical
• 6.58. Operon
• 6.59. OraSure Technologies
• 6.60. Qiagen
• 6.61. QuidelOrtho
• 6.62. R&D Systems
• 6.63. Randox Toxicology
• 6.64. R-Biopharm AG
• 6.65. Response Biomedical
• 6.66. Revvity
• 6.67. Roche Diagnostics
• 6.68. SD Biosensor
• 6.69. Siemens Healthineers
• 6.70. Standard BioTools
• 6.71. Sysmex
• 6.72. Tecan
• 6.73. Thermo Fisher Scientific
• 6.74. TOSOH Bioscience
• 6.75. Uniogen
• 6.76. Veramarx
• 6.77. Veredus Laboratories
• 6.78. Vircell
• 6.79. Wantai Biopharm
• 6.80. Werfen
• 6.81. YD Diagnostics
• 6.82. Zhejiang Orient Gene Biotech

7. The Global Market

• 7.1. Global Market by Country
  • 7.1.1. Global Market by Country Table
  • 7.1.2. Global Market by Country Chart
• 7.2. Global Market by Application
  • 7.2.1. Global Market by Application Table
  • 7.2.2. Global Market by Application Segment Growth Chart
  • 7.2.3. Global Market by Application Segment Annual Chart
  • 7.2.4. Global Market by Application Segment Base vs. Final
  • 7.2.5. Global Market by Application Base Year
  • 7.2.6. Global Market by Application Final Year
• 7.3. Global Market by Technology
  • 7.3.1. Global Market by Technology Table
  • 7.3.2. Global Market by Technology Segment Growth Chart
  • 7.3.3. Global Market by Technology Segment Annual Chart
  • 7.3.4. Global Market by Technology Segment Base vs. Final
  • 7.3.5. Global Market by Technology Base Year
  • 7.3.6. Global Market by Technology Final Year
• 7.4. Global Market by Product
  • 7.4.1. Global Market by Product Table
  • 7.4.2. Global Market by Product Segment Growth Chart
  • 7.4.3. Global Market by Product Segment Annual Chart
  • 7.4.4. Global Market by Product Segment Base vs. Final
  • 7.4.5. Global Market by Product Base Year
  • 7.4.6. Global Market by Product Final Year
• 7.5. Global Market by User
  • 7.5.1. Global Market by User Table
  • 7.5.2. Global Market by User Segment Growth Chart
  • 7.5.3. Global Market by User Segment Annual Chart
  • 7.5.4. Global Market by User Segment Base vs. Final
  • 7.5.5. Global Market by User Base Year
  • 7.5.6. Global Market by Application Final Year

8. Global Market by Application

• 8.1. Endocrinology Applications
  • 8.1.1. Endocrinology Applications by Country Table
  • 8.1.2. Endocrinology Applications Growth Chart
• 8.2. Immune Applications
  • 8.2.1. Immune Applications by Country Table
  • 8.2.2. Immune Applications Growth Chart
• 8.3. Oncology Applications
  • 8.3.1. Oncology Applications by Country Table
  • 8.3.2. Oncology Applications Growth Chart
• 8.4. Infectious Disease Applications
  • 8.4.1. Infectious Disease Applications by Country Table
  • 8.4.2. Infectious Disease Applications Growth Chart
• 8.5. Cardiology Applications
  • 8.5.1. Cardiology Applications by Country Table
  • 8.5.2. Cardiology Applications Growth Chart
• 8.6. Other Applications
  • 8.6.1. Other Applications by Country Table
  • 8.6.2. Other Applications Growth Chart

9. Immunoassay by Technology

• 9.1. Enzyme
  • 9.1.1. Enzyme by Country Table
  • 9.1.2. Enzyme Growth Chart
• 9.2. Flourescence
  • 9.2.1. Flourescence by Country Table
  • 9.2.2. Flourescence Growth Chart
• 9.3. Chemiluminescence
  • 9.3.1. Chemiluminescence by Country Table
  • 9.3.2. Chemiluminescence Growth Chart
• 9.4. Nucleic Acid
  • 9.4.1. Nucleic Acid by Country Table
  • 9.4.2. Nucleic Acid Growth Chart
• 9.5. Rapid/POC
  • 9.5.1. Rapid/POC by Country Table
  • 9.5.2. Rapid/POC Growth Chart
• 9.6. Other Technology
  • 9.6.1. Other Technology by Country Table
  • 9.6.2. Other Technology Growth Chart

10. Immunoassay by Product

• 10.1. Instrument
  • 10.1.1. Instrument by Country Table
  • 10.1.2. Instrument Growth Chart
• 10.2. Reagents
  • 10.2.1. Reagents by Country Table
  • 10.2.2. Reagents Growth Chart
• 10.3. Services
  • 10.3.1. Services by Country Table
  • 10.3.2. Services Growth Chart

11. Immunoassay by User

• 11.1. Hospital
  • 11.1.1. Hospital by Country Table
  • 11.1.2. Hospital Growth Chart
• 11.2. Outpatient Lab
  • 11.2.1. Outpatient Lab by Country Table
  • 11.2.2. Outpatient Lab Growth Chart
• 11.3. POC/Other
  • 11.3.1. POC/Other by Country Table
  • 11.3.2. POC/Other Growth Chart

12. Vision of the Future of Immunoassay

13. Appendices

• 13.1. Growth of Approved IVD Test Menu
• 13.2. Growth of Approved Average IVD Test Fee
• 13.3. The Most Used IVD Assays
• 13.4. The Highest Grossing Assays
• 13.5. Laboratory Fees Schedule